Intertumoral heterogeneity of the immune microenvironment in high grade canine mast cell tumors.

Veterinary oncology (London, England) Pub Date : 2025-01-01 Epub Date: 2025-03-14 DOI:10.1186/s44356-025-00020-9
K L Bardales, L Jiang, E Radaelli, C A Assenmacher, J A Lenz, M J Atherton
{"title":"Intertumoral heterogeneity of the immune microenvironment in high grade canine mast cell tumors.","authors":"K L Bardales, L Jiang, E Radaelli, C A Assenmacher, J A Lenz, M J Atherton","doi":"10.1186/s44356-025-00020-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Canine cutaneous mast cell tumors (MCTs) are a common, yet clinically challenging tumor type given their variable biological behavior. Although patients with low grade MCTs can often be effectively managed with surgery alone, most dogs with high grade MCTs succumb to their disease despite multimodal therapy. An improved understanding of the immune tumor microenvironment (TME) may help identify novel prognostic and therapeutic targets.</p><p><strong>Methods: </strong>In this study, we interrogated the immune transcriptional profiles of the TME in low and high grade MCTs, and quantified intratumoral T cells. Twelve client-owned dogs with MCTs (6 Kiupel low grade with clinically benign behavior and 6 Kiupel high grade with clinically aggressive behavior) that underwent curative-intent surgery were selected. Tumor grade was confirmed by a single veterinary pathologist. RNA was extracted from all tumors followed by immune transcriptional profiling utilizing the NanoString Canine IO panel and analysis using the ROSALIND platform. T cell density was determined by immunohistochemical staining for CD3 and quantified using ImageScope software (Leica Biosystems) following digital slide capture. Lymphocytic infiltrate was further characterized in the TME of one high grade MCT using co-immunofluorescence.</p><p><strong>Results: </strong>Immune transcriptional profiling identified 9 differentially expressed genes between low and high grade MCTs (p-adj < 0.05). Programmed cell death protein 1 (<i>PDCD1</i>) and inducible T-cell costimulator ligand (<i>ICOSLG</i>) gene expression were significantly higher in a subset of high grade MCTs. <i>ICOSLG</i> expression positively correlated with T cell score (r<sub>s</sub> = 0.6434, <i>p</i> = 0.0278). Although the T cell density was not significantly different between low (mean of 76.42 CD3 + /mm<sup>2</sup>, SD 12 CD3 + /mm<sup>2</sup>) and high grade MCTs (mean of 129.1 CD3 + /mm<sup>2</sup>, SD 96.06 CD3 + /mm<sup>2</sup>), greater variation of T cell densities was observed across high grade MCTs compared to low grade (<i>p</i> = 0.0059). Immunofluorescence of one high grade MCT with marked T cell infiltration revealed organized aggregates of T and B cells consistent with tertiary lymphoid structures (TLS).</p><p><strong>Conclusions: </strong>Our data revealed significant differences in the immune TME of low and high grade MCTs and provides rationale to further investigate potential prognostic and therapeutic roles of immune checkpoints in canine MCTs.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1186/s44356-025-00020-9.</p>","PeriodicalId":520417,"journal":{"name":"Veterinary oncology (London, England)","volume":"2 1","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11906493/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary oncology (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s44356-025-00020-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Canine cutaneous mast cell tumors (MCTs) are a common, yet clinically challenging tumor type given their variable biological behavior. Although patients with low grade MCTs can often be effectively managed with surgery alone, most dogs with high grade MCTs succumb to their disease despite multimodal therapy. An improved understanding of the immune tumor microenvironment (TME) may help identify novel prognostic and therapeutic targets.

Methods: In this study, we interrogated the immune transcriptional profiles of the TME in low and high grade MCTs, and quantified intratumoral T cells. Twelve client-owned dogs with MCTs (6 Kiupel low grade with clinically benign behavior and 6 Kiupel high grade with clinically aggressive behavior) that underwent curative-intent surgery were selected. Tumor grade was confirmed by a single veterinary pathologist. RNA was extracted from all tumors followed by immune transcriptional profiling utilizing the NanoString Canine IO panel and analysis using the ROSALIND platform. T cell density was determined by immunohistochemical staining for CD3 and quantified using ImageScope software (Leica Biosystems) following digital slide capture. Lymphocytic infiltrate was further characterized in the TME of one high grade MCT using co-immunofluorescence.

Results: Immune transcriptional profiling identified 9 differentially expressed genes between low and high grade MCTs (p-adj < 0.05). Programmed cell death protein 1 (PDCD1) and inducible T-cell costimulator ligand (ICOSLG) gene expression were significantly higher in a subset of high grade MCTs. ICOSLG expression positively correlated with T cell score (rs = 0.6434, p = 0.0278). Although the T cell density was not significantly different between low (mean of 76.42 CD3 + /mm2, SD 12 CD3 + /mm2) and high grade MCTs (mean of 129.1 CD3 + /mm2, SD 96.06 CD3 + /mm2), greater variation of T cell densities was observed across high grade MCTs compared to low grade (p = 0.0059). Immunofluorescence of one high grade MCT with marked T cell infiltration revealed organized aggregates of T and B cells consistent with tertiary lymphoid structures (TLS).

Conclusions: Our data revealed significant differences in the immune TME of low and high grade MCTs and provides rationale to further investigate potential prognostic and therapeutic roles of immune checkpoints in canine MCTs.

Supplementary information: The online version contains supplementary material available at 10.1186/s44356-025-00020-9.

高分级犬肥大细胞瘤免疫微环境的肿瘤间异质性。
背景:犬皮肤肥大细胞瘤(mct)是一种常见的,但临床上具有挑战性的肿瘤类型,由于其多变的生物学行为。虽然低级别mct患者通常可以通过单独手术有效地治疗,但大多数患有高级别mct的狗尽管采用了多种治疗方法,但仍死于疾病。提高对免疫肿瘤微环境(TME)的理解可能有助于确定新的预后和治疗靶点。方法:在这项研究中,我们询问了低和高级别mct中TME的免疫转录谱,并量化了肿瘤内T细胞。选择12只患有mct的客户拥有的狗(6只Kiupel低级别,临床行为为良性,6只Kiupel高级别,临床行为为攻击性)进行治疗目的手术。肿瘤分级由一名兽医病理学家确认。从所有肿瘤中提取RNA,然后利用NanoString犬IO面板进行免疫转录分析,并使用ROSALIND平台进行分析。T细胞密度采用CD3免疫组化染色测定,数字切片采集后使用ImageScope软件(Leica Biosystems)定量。淋巴细胞浸润在一个高级别MCT的TME中进一步使用免疫荧光进行表征。结果:免疫转录谱鉴定出9个在低级别和高级别mct之间差异表达的基因(p-adj PDCD1)和诱导t细胞共刺激配体(ICOSLG)基因表达在高级别mct亚群中显著更高。ICOSLG表达与T细胞评分呈正相关(rs = 0.6434, p = 0.0278)。虽然T细胞密度在低级别mct(平均为76.42 CD3 + /mm2, SD为12 CD3 + /mm2)和高级别mct(平均为129.1 CD3 + /mm2, SD为96.06 CD3 + /mm2)之间没有显著差异,但与低级别mct相比,高级别mct的T细胞密度差异更大(p = 0.0059)。免疫荧光显示一个高级别MCT有明显的T细胞浸润,显示有组织的T细胞和B细胞聚集,与三级淋巴结构(TLS)一致。结论:我们的数据揭示了低级别和高级别mct免疫TME的显著差异,并为进一步研究免疫检查点在犬mct中的潜在预后和治疗作用提供了依据。补充资料:在线版本提供补充资料,网址为10.1186/s44356-025-00020-9。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信